yellow diarrhea semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide vs Tirzepatide for Weight

We offer other medications and treatments to support your weight loss journey, which can keep the dosage of semaglutide and tirzepatide lower and help you transition off the medications

[DOI] [PMC free article] [PubMed] [Google Scholar] Mathiesen I

By simultaneously activating the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, it effectively promotes insulin secretion and reduces glucagon release, leading to better blood sugar regulation and weight loss support

Semaglutide and other GLP-1 receptor agonists work by mimicking a hormone that signals fullness and slows stomach emptying

One of them is to help make more insulin, which lowers your blood sugar levels